ProQR Therapeutics (PRQR) Cash from Operations (2013 - 2022)
ProQR Therapeutics recorded quarterly Cash from Operations of 14370184.14 in Q4 2022, up 7.24% quarter-over-quarter from 15491126.8 in Q3 2022, and down 431.88% year-over-year from 4329930.05 in Q4 2021.
ProQR Therapeutics' Cash from Operations history runs 10 years deep, the most recent figure standing at 14370184.14 for Q4 2022.
- In Q4 2022, Cash from Operations fell 431.88% year-over-year to 14370184.14; the TTM figure through Dec 2022 stood at 68671586.5 (down 118.87% YoY), while the FY2025 annual figure was 61451021.18, down 58.01% from the prior year.
- Cash from Operations came in at 14370184.14 for Q4 2022 at ProQR Therapeutics, up from 15491126.8 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 4329930.05 in Q4 2021 to a low of 22970886.08 in Q1 2022.
- A 5-year average of 9889811.11 and a median of 11784218.53 in 2021 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations plunged 117807262.15% in 2019 and soared 130.89% in 2021, its largest moves.
- ProQR Therapeutics' Cash from Operations stood at 10390.13 in 2018, then tumbled by 127270.37% to 13233949.02 in 2019, then fell by 5.91% to 14016559.47 in 2020, then soared by 130.89% to 4329930.05 in 2021, then plunged by 431.88% to 14370184.14 in 2022.
- According to Business Quant data, Cash from Operations over the past three periods registered 14370184.14, 15491126.8, and 15839389.48 for Q4 2022, Q3 2022, and Q2 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.43 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.08 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 70.50 Mn |
| 10 | ProQR Therapeutics | 174.11 Mn | 66.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -14.37 Mn |
| Dec 31, 2022 | -14.37 Mn |
| Sep 30, 2022 | -15.49 Mn |
| Sep 30, 2022 | -15.49 Mn |
| Jun 30, 2022 | -15.84 Mn |
| Jun 30, 2022 | -15.84 Mn |
| Mar 31, 2022 | -22.97 Mn |
| Mar 31, 2022 | -22.97 Mn |
| Dec 31, 2021 | 4.33 Mn |
| Dec 31, 2021 | 4.33 Mn |
| Sep 30, 2021 | -9.50 Mn |
| Sep 30, 2021 | -9.50 Mn |
| Jun 30, 2021 | -12.02 Mn |
| Jun 30, 2021 | -12.02 Mn |
| Mar 31, 2021 | -14.19 Mn |
| Mar 31, 2021 | -14.19 Mn |
| Dec 31, 2020 | -14.02 Mn |
| Dec 31, 2020 | -14.02 Mn |
| Sep 30, 2020 | -11.46 Mn |
| Sep 30, 2020 | -11.46 Mn |
| Jun 30, 2020 | -11.55 Mn |
| Jun 30, 2020 | -11.55 Mn |
| Mar 31, 2020 | -16,566.81 |
| Mar 31, 2020 | -16,566.81 |
| Dec 31, 2019 | -13.23 Mn |
| Dec 31, 2019 | -13.23 Mn |
| Sep 30, 2019 | -9.76 Mn |
| Sep 30, 2019 | -9.76 Mn |
| Jun 30, 2019 | -12.22 Mn |
| Jun 30, 2019 | -12.22 Mn |
| Mar 31, 2019 | -14.05 Mn |
| Mar 31, 2019 | -14.05 Mn |
| Dec 31, 2018 | -10,390.13 |
| Dec 31, 2018 | -10,390.13 |
| Sep 30, 2018 | -4.95 Mn |
| Sep 30, 2018 | -4.95 Mn |
| Jun 30, 2018 | -6.47 Mn |
| Jun 30, 2018 | -6.47 Mn |
| Mar 31, 2018 | 11.93 |
| Mar 31, 2018 | 11.93 |
| Dec 31, 2017 | 10,261.32 |
| Dec 31, 2017 | 10,261.32 |
| Sep 30, 2017 | 8.94 |
| Sep 30, 2017 | 8.94 |
| Jun 30, 2017 | -10.83 Mn |
| Jun 30, 2017 | -10.83 Mn |
| Mar 31, 2017 | 9,357.47 |
| Mar 31, 2017 | 9,357.47 |
| Dec 31, 2016 | -36.92 Mn |
| Dec 31, 2016 | -36.92 Mn |
| Sep 30, 2016 | -12,046.98 |
| Sep 30, 2016 | -12,046.98 |
| Dec 31, 2015 | -26.54 Mn |
| Dec 31, 2015 | -26.54 Mn |
| Sep 30, 2015 | -6,967.35 |
| Sep 30, 2015 | -6,967.35 |
| Mar 31, 2015 | -5.96 Mn |
| Mar 31, 2015 | -5.96 Mn |
| Dec 31, 2014 | -6.23 Mn |
| Dec 31, 2014 | -6.23 Mn |
| Sep 30, 2014 | -5.71 Mn |
| Sep 30, 2014 | -5.71 Mn |
| Mar 31, 2014 | -2.65 Mn |
| Mar 31, 2014 | -2.65 Mn |
| Dec 31, 2013 | -1.26 Mn |
| Dec 31, 2013 | -1.26 Mn |
| Sep 30, 2013 | -1.03 Mn |
| Sep 30, 2013 | -1.03 Mn |